Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case–Control Study
Antonio Russo, Giuseppina Dell’Aquila, Fabio Giuliano Numis(Ospedale Santa Maria), Grazia Russo(Ospedale Santa Maria), Paolo Maggi(Università degli Studi di Enna Kore), Elio Manzillo(Ospedale Monaldi), N Sangiovanni(Ospedale D. Cotugno), Verdiana Zollo(University of Campania "Luigi Vanvitelli"), Mariantonietta Pisaturo(University of Antwerp), Roberto Parrella(Ospedale D. Cotugno), Anna Maria Rossomando(Ospedale D. Cotugno), Michele Gambardella, Lorenzo Onorato(University of Campania "Luigi Vanvitelli"), Ivan Gentile(University of Naples Federico II), Vincenzo Bianco, Salvatore Martini(University of Campania "Luigi Vanvitelli"), Antonio Ponticiello(Ospedale Sant'Anna), Alfonso Masullo(Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona), Raffaella Pisapia(University of Naples Federico II), Giosuele Calabria(Ospedale D. Cotugno), Alessio Vinicio Codella(Azienda Ospedaliera G.Rummo)
Cited by 26
Related Papers
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)
|Clinical Infectious Diseases|2023|156
Cardiovascular risk and dyslipidemia among persons living with HIV: a review
|BMC Infectious Diseases|2017|152
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
|Diabetes & Metabolism|2020|138